These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24911522)

  • 1. Unchanged plasma levels of the soluble urokinase plasminogen activator receptor in elective coronary artery bypass graft surgery patients and cardiopulmonary bypass use.
    Gozdzik W; Adamik B; Gozdzik A; Rachwalik M; Kustrzycki W; Kübler A
    PLoS One; 2014; 9(6):e98923. PubMed ID: 24911522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cardiopulmonary bypass and surgical complexity on plasma soluble urokinase-type plasminogen activator receptor levels after cardiac surgery.
    Dardashti A; Sterner N; Fisher J; Thelaus L; Nilsson J; Linder A; Zindovic I
    Scand J Clin Lab Invest; 2021 Dec; 81(8):634-640. PubMed ID: 34657538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Urokinase Receptor and Acute Kidney Injury.
    Hayek SS; Leaf DE; Samman Tahhan A; Raad M; Sharma S; Waikar SS; Sever S; Camacho A; Wang X; Dande RR; Ibrahim NE; Baron RM; Altintas MM; Wei C; Sheikh-Hamad D; Pan JS; Holliday MW; Januzzi JL; Weisbord SD; Quyyumi AA; Reiser J
    N Engl J Med; 2020 Jan; 382(5):416-426. PubMed ID: 31995687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery.
    Rasmussen SR; Nielsen RV; Møgelvang R; Ostrowski SR; Ravn HB
    BMC Nephrol; 2021 Apr; 22(1):120. PubMed ID: 33827466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) and high-sensitivity C-reactive protein after Roux-en-Y gastric bypass or sleeve gastrectomy: a 1-year prospective observational study.
    Kokkinos A; Liaskos C; Alexiadou K; Papassotiriou I; Margeli A; Argyrakopoulou G; Perrea D; Alexandrou A; Katsilambros N; Diamantis T; Tentolouris N
    J Endocrinol Invest; 2021 Mar; 44(3):599-608. PubMed ID: 32681464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery.
    Mossanen JC; Pracht J; Jansen TU; Buendgens L; Stoppe C; Goetzenich A; Struck J; Autschbach R; Marx G; Tacke F
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor-15 (GDF-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Kahli A; Guenancia C; Zeller M; Grosjean S; Stamboul K; Rochette L; Girard C; Vergely C
    PLoS One; 2014; 9(8):e105759. PubMed ID: 25171167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cardiopulmonary bypass on tissue injury markers and endothelial activation during coronary artery bypass graft surgery.
    Nair S; Iqbal K; Phadke M; Jadhav UE; Khandekar J; Khandeparkar JM
    J Postgrad Med; 2012; 58(1):8-13. PubMed ID: 22387642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
    Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A; Sujatha DI; Ninan B; Vijayalakshmi MA
    Ann Vasc Surg; 2010 May; 24(4):525-31. PubMed ID: 20363104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
    Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
    Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
    Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
    Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments.
    Alstrup M; Meyer J; Schultz M; Rasmussen LJH; Rasmussen LS; Køber L; Forberg JL; Eugen-Olsen J; Iversen K
    World J Surg; 2019 Mar; 43(3):780-790. PubMed ID: 30390135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes.
    Peiró ÓM; Cediel G; Bonet G; Rojas S; Quintern V; Carrasquer A; González-Del-Hoyo M; Sanz E; Bardají A
    Biomarkers; 2020 Jul; 25(5):402-409. PubMed ID: 32551985
    [No Abstract]   [Full Text] [Related]  

  • 16. SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.
    Hodges G; Lyngbæk S; Selmer C; Ahlehoff O; Theilade S; Sehestedt TB; Abildgaard U; Eugen-Olsen J; Galløe AM; Hansen PR; Jeppesen JL; Bang CN
    Scand Cardiovasc J; 2020 Dec; 54(6):339-345. PubMed ID: 32400206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass.
    Hsing CH; Hsieh MY; Chen WY; Cheung So E; Cheng BC; Chang MS
    Ann Thorac Surg; 2006 Jun; 81(6):2196-201. PubMed ID: 16731153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome.
    Chenevier-Gobeaux C; Lemarechal H; Doumenc B; Peschanski N; Claessens YE; Borderie D; Ray P
    Clin Biochem; 2021 Jun; 92():19-24. PubMed ID: 33662350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass.
    TAMAYO E; ALVAREZ FJ; ALONSO O; BUSTAMANTE R; CASTRODEZA J; SORIA S; LAJO C
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):687-94. PubMed ID: 19741581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
    Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
    J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.